BlackRock, Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for RECURSION PHARMACEUTICALS, INC. Class A Common Stock (RXRX)

Filing Manager
BlackRock, Inc.
Reporting Manager
BlackRock, Inc.
Security
RECURSION PHARMACEUTICALS, INC. Class A Common Stock
Symbol
RXRX
Shares outstanding
384,207,148 shares
Disclosed Ownership
23,436,636 shares
Ownership
6.1%
Form type
SCHEDULE 13G/A
Filing time
05 Feb 2025, 17:28:46 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"BlackRock, Inc. disclosed 6.1% ownership in RECURSION PHARMACEUTICALS, INC. Class A Common Stock (RXRX) on 31 Dec 2024."

Quick Takeaways

  • BlackRock, Inc. filed SCHEDULE 13G/A for RECURSION PHARMACEUTICALS, INC. Class A Common Stock (RXRX).
  • Disclosed ownership: 6.1%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 05 Feb 2025, 17:28.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BlackRock, Inc. 6.1% 23,436,636 22,966,295 0 Spencer Fleming Managing Director

Sponsored